|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [740]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [740]
pendence: A review of the evidence for its hypothesized mechanisms of action. Addiction, 95, 1475–1490.
Morrisey, E., Wandersmand, A., Seybolt, D., Nation, M., Crusto, C., & Davino, K. (1997). Toward a framework for bridging the gap between science and practice in prevention: A focus on evaluator and practitioner perspectives. Evaluation and Program Planning, 20, 367–377.
Mrazek, P. J., & Haggerty, K. (1994). Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research. Washington, DC.: National Academy Press.
MTP Research Group (Babor, T. F., Carroll, K. M., Christiansen, K., Kadden, R., Litt, M., & McRee, B. (2004). Brief treatments for cannabis dependence. Findings from a randomized multisite trial. Journal of Consulting and Clinical Psychology, 72, 455–466.
Myers, M. G., Stewart, D. G., & Brown, S. A. (1998). Progression from conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse. American Journal of Psychiatry, 155, 479–485.
National Center on Alcohol and Substance Abuse (CASA). (2003). Teen tipplers: America's underage drinking epidemic. The National Center on Addiction and Substance Abuse at Columbia University. New York: Columbia University.
National Commission on Marihuana (1972). Marihuana: A signal of misunderstanding. Washington, DC: Government Printing Office.
National Institute on Drug Abuse. (2000). Principles of drug abuse treatment: A research-based guide. Bethesda, Maryland: NIDA.
National Research Council and Institute of Medi
cine (NRCIM). (2003). Reducing underage drinking: A collective responsibility. Washington, DC: The National Academies Press.
Newcomb, M. D. (1997). Psychosocial predictors and consequences of drug use: A developmental perspective within a prospective study. Journal of Addictive Diseases, 16, 51–89.
Nielsen, D. A., Virkkunen, M., Lappalainen, J., Eggert, M., Brown, G. L., Long, J. C., et al. (1998). A tryptophan hydroxylase gene marker for suicidality and alcoholism. Archives of General Psychiatry, 55, 593–602.
Noble, E., Ozkaragoz, T., Ritchie, T., Zhang, X., Belin, T., & Sparkes, R. (1998). D2 and D4 dopamine receptor polymorphisms and personality. American Journal of Medical Genetics, 81, 257–267.
Noble, E., St Jeor, S. T., Ritchie, T., Syndulko, K., St Jeor, S. C., Fitch, R., & Brunner, R. L. (1994). D2 dopamine receptor gene and cigarette smok-ing: a reward gene? Medical Hypotheses, 42, 257–260.
O'Brien, C. (2001). Drug addiction and drug abuse. In J. G. Hardman & C. L. Lee (Eds.), Goodman & Gilman's the pharmacological basis of therapeutics (10th ed., pp. 621–642). New York: McGraw-Hill.
O'Brien, C. P., Childress, A. R., Ehrman, R., & Robbins, S. J. (1998). Conditioning factors in drug abuse: Can they explain compulsion? Journal of Psychopharmacology, 12, 15–22.
O'Brien, C. P., Childress, A. R., McLellan, A. T., & Ehrman, R. (1992). Classical conditioning in drug-dependent humans. Annals of the New York Academy of Science, 654, 400–415.
O'Brien, C. P., Testa, T., O'Brien, T. J., Brady, J. P., & Wells, B. (1977). Conditioning narcotic withdrawal in humans. Science, 195, 1000–1002.
Obrocki, J., Schmoldt, A., Buchert, R., Andresen, B., Petersen, K., & Thomasius, R. (2002). Specific neurotoxicity of chronic use of ecstasy. Toxicology Letters, 127, 285–297.
Olds, D., Robinson, J., Song, N., Little, C., & Hill, P. (1999). Reducing risks for mental disorders during the first five years of life: A review of pre
end p.740
|
|
|
|
